Search Results 71-80 of 11918 for Rimegepant

  1. Neratinib (oral route) - Mayo Clinic

    Neratinib is used to treat patients with HER2-overexpressed or amplified breast cancer that has been previously treated with trastuzumab. Neratinib is also used ...

  2. Bicalutamide (oral route) - Mayo Clinic

    Bicalutamide is used together with a luteinizing hormone releasing hormone (LHRH) analog (eg, goserelin or leuprolide) to treat stage D2 metastatic prostate ...

  3. Neurosurgery - Clinical trials

    Learn how neurosurgeons help people with complex conditions by using advanced techniques, such as awake brain surgery and minimally invasive spine surgery.

  4. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  5. Ombitasvir, paritaprevir, ritonavir and dasabuvir (oral route) - Side effects & dosage - Mayo Clinic

    Ombitasvir, paritaprevir, ritonavir, and dasabuvir combination is used with or without ribavirin to treat chronic hepatitis C infection, including patients with ...

  6. Ipilimumab With Or Without Talimogene Laherparepvec In Unresected Melanoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Hematology - Clinical trials

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...

  8. Gemcitabine Hydrochloride Alone Or With M6620 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer - Mayo Clinic

    About this study. This randomized phase II trial studies how well ATR kinase inhibitor M6620 (M6620) and gemcitabine hydrochloride work compared to standard ...

  9. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...

  10. Nintedanib (oral route) - Mayo Clinic

    This medicine is also used to slow the rate of decline in lung function in people with systemic sclerosis-associated interstitial lung disease. Nintedanib ...